Effect of Baladi Ghrita along with Ferrous Ascorbate in the Treatment of Pica associated Anemia

Study of add on effect of Baladi Ghrita along with ferrous ascorbate in the management of Mridbhakshanjanya Pandu- A Randomized, Controlled, Clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058275

Enrollment

Registered

2023-10-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient will be selected irrespective of their gender, caste and socioeconomic status. 2. Patient’s age group between 2-6 years. 3. Hb% >8 gm/dl and <11gm/dl

Exclusion criteria

Exclusion criteria: 1) Patient having any major systemic illness. 2) Patients below 2 year and above 6 years. 3) Patients with defective iron absorption in condition like gastrostomy, gastro-jejunostomy. 4) Anemia due to chronic illness like malaria, T.B, Leukemia, etc . 5) K/C/O Congenital anomalies, ADHD, Mentally retarded. 6) Hb% 11 gm/dl

Design outcomes

Primary

Measure	Time frame
Study of add on effect of Baladi Ghrita in the management of Mridbhakshanjanya Pandu when given orally along with ferrous ascorbate on Pallor, Hb% , MCV, RDW-CVTimepoint: 4 Weeks	—

Secondary

Measure	Time frame
To study the clinical appearance of Mridbhakshanjany Pandu occurring in Children according to both Ayurvedic & modern point of view.Timepoint: 8 weeks	—

Countries

India

Contacts

Public ContactDr Deokumar W Raut

Government Ayurved College and hospital Vajirabad Nanded

rautdeokumar@gmail.com9823935698

Outcome results